BioIntelliSense's last reported valuation, Dec 2022. Nothing priced has surfaced since.
- ·The complete investor list: 18 names
- ·Watch BioIntelliSense: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
BioIntelliSense funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | Later Stage VC | $58.3M | ▮ | ▮ |
| Apr 2021 | Early Stage VC | $45.0M | ▮ | ▮ |
| Aug 2020 | Early Stage VC | $12.0M | ▮ | ▮ |
| Dec 2018 | Early Stage VC | $25.0M | ▮ | ▮ |
Membership and data by Private Market View
BioIntelliSense valuation
BioIntelliSense's last reported valuation was $1.2 billion in Dec 2022. No priced round, secondary trade or fund mark has surfaced since.
How much has BioIntelliSense raised?
BioIntelliSense has raised $319 million in total; 4 of its rounds are on record, from 2018 on. The largest on record was a $58.3 million later-stage round in Dec 2025.
BioIntelliSense has filed 4 Form Ds with the SEC since 2020, most recently in Dec 2025 ($58.1 million sold to 4 investors).
How BioIntelliSense's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For BioIntelliSense, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about BioIntelliSense
- What is BioIntelliSense worth?
- BioIntelliSense is valued at $1.2B as of Oct 2026. BioIntelliSense's last reported valuation, Dec 2022. Nothing priced has surfaced since.
- How much has BioIntelliSense raised?
- BioIntelliSense has raised $318.6M in total funding across 4 recorded rounds.
- When did BioIntelliSense last raise?
- BioIntelliSense last raised in Dec 2025 (Later Stage VC), raising $58.3M.